ÂÜÀòÂÒÂ×

Andrew Mullen is a seasoned executive with extensive experience in operations and strategic leadership within the medical technology sector. As Chief Executive Officer and Chief Operating Officer at Charco since March 2024, Andrew has previously held significant roles including Chief Operating Officer at OxSonics Therapeutics, where responsibilities included leading strategic business plans and coordinating senior management activities. Experience spans various leadership positions at Creavo Medical Technologies, Xstrahl, and Gulmay Medical Ltd, focusing on operational efficiency, quality assurance, and compliance across multiple international markets. Andrew began a technical career in the Royal Navy, culminating in project management for advanced systems. Educational achievements include an MBA with distinction from the University of South Wales and various qualifications in project management and engineering.